CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced interim ...

Argenx discontinues its Phase 3 UplighTED trial in thyroid eye disease after an interim futility review, while analysts ...

Analysis of 97 lakh Tamil Nadu voter deletions reveals anomalies: high young deaths, 100% death-based removals in 495 stations, and significant gender bias ...

The risk for a diagnosis of epilepsy is more than two times greater for those with depression, although incidence is low, ...

Orca-T immunotherapy shows promising results in improving survival and reducing complications in patients with hematologic ...

Landmark results could pave the way for miv-cel to become the first FDA-approved CAR T-cell therapy for autoimmune disease; Company on track to submit BLA for stiff person syndrome in 1H 2026 Miv-cel ...

Analysis of 4.37 million patient records in England finds resources asymmetrically impacted by winter cold and summer heat, with about 64% linked to common cold days while very hot days drive sharp sa ...

Background Out-of-hours primary care (OOH-PC) services are complex clinical environments where suboptimal care may occur.

People hoping to obtain a student visa in Canada may have some hope based on recent approval data from a Canadian educational ...

Objective To determine whether a full-scale randomised control trial (RCT) assessing the efficacy and cost-effectiveness of a ...

According to editorialists, the study has the potential for major clinical impact, but more work is needed before guidelines should change.

Global Hematology Market OverviewThe global hematology market is projected to grow at a CAGR of approximately 3–5% through ...